Network Profiles Alexander Drilon

(1 - 18 from 19
)

Cabozantinib and Cobimetinib to Be Featured in Fourteen Presentations...

ir.exelixis.com
Abstract 8007: “Phase II study of cabozantinib for patients with advanced RET-rearranged lung cancers.” Dr. Alexander Drilon , Memorial Sloan ...
+1